When “One Size Fits All” Fits None: A Commentary on the Impacts of the“Draft Canadian Breast Cancer Screening Guidelines” on Racialized Populations in Canada
Open Access
- 22 February 2025
- journal article
- review article
- Published by MDPI AG in Current Oncology
- Vol. 32 (3) , 123
Abstract
Epidemiological data show racial and ethnic differences exist in breast cancer morbidity and mortality amongst Black, Indigenous, Asian, and Hispanic populations, with non-white females experiencing earlier age at diagnosis, more aggressive breast cancer subtypes and advanced cancer stages, and earlier mortality than white females. However, the current Canadian breast cancer screening guidelines recommend biannual screening for all females starting from age 50 to age 74 and suggest not to screen individuals aged 40–49. In May 2024, the Canadian Task Force for Preventative Health released updated draft breast cancer screening guidelines, maintaining such recommendations for screening. Both the existing and the proposed guidelines fail to account for the unique cancer burden amongst racialized populations in Canada and risk further perpetuation of existing racial and ethnic disparities by underscreening racialized females. This commentary will present data regarding racial disparities in cancer burden, highlighting the role social and biological factors play in impacting cancer risk and age of disease and presenting perspectives from stakeholder groups reflecting the impacts of current screening guidelines. Ultimately, we critique the current “one-size-fits-all” approach to breast cancer screening in Canada, emphasizing the need for adapted screening practices with the understanding that the current approaches overlook the needs of racialized Canadian populations.Keywords
Funding Information
- CIHR (WI3-179971)
This publication has 61 references indexed in Scilit:
- Screening for Breast CancerJAMA, 2024
- Race and Ethnicity–Adjusted Age Recommendation for Initiating Breast Cancer ScreeningJAMA Network Open, 2023
- Race/Ethnicity and Age Distribution of Breast Cancer Diagnosis in the United StatesJAMA Surgery, 2018
- Reporting Sex, Gender, or Both in Clinical Research?JAMA, 2016
- Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American womenCancer, 2011
- African ancestry and higher prevalence of triple‐negative breast cancerCancer, 2010
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Racial disparities in breast carcinoma survival ratesCancer, 2003
- A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results programCancer, 1997